Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
about
The endocannabinoid system in normal and pathological brain ageingThe importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseIs lipid signaling through cannabinoid 2 receptors part of a protective system?TSPO imaging in parkinsonian disordersExpression and Function of the Endocannabinoid System in the Retina and the Visual BrainThe choreography of neuroinflammation in Huntington's diseaseTime-Dependent Protection of CB2 Receptor Agonist in StrokeEvidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative painR-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoidsAAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's diseaseTargeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative DisordersCannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's DiseaseRole of cannabinoids in multiple sclerosisIn vitro and in vivo models of Huntington's disease show alterations in the endocannabinoid systemRegulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice.Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.Mutant huntingtin impairs immune cell migration in Huntington disease.Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.Brain CB₂ Receptors: Implications for Neuropsychiatric Disorders.Potential future neuroprotective therapies for neurodegenerative disorders and stroke.A restricted population of CB1 cannabinoid receptors with neuroprotective activityMicroglial Activation in the Pathogenesis of Huntington's Disease.Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factorsThe endocannabinoid system as a target for the treatment of neurodegenerative disease.Cannabinoid receptor type 2 agonist attenuates apoptosis by activation of phosphorylated CREB-Bcl-2 pathway after subarachnoid hemorrhage in rats.Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6/2 mice and 3-nitropropionate-lesioned mice.The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects.Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.Minocycline attenuates cognitive impairment induced by isoflurane anesthesia in aged ratsMolecular reorganization of endocannabinoid signalling in Alzheimer's diseaseMotor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189CB2 receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120.Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuropathologic comorbidities.Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts.The therapeutic potential of cannabinoids for movement disorders.The role of the immune system in triplet repeat expansion diseasesPromising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionCB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures.Sativex-like combination of phytocannabinoids is neuroprotective in malonate-lesioned rats, an inflammatory model of Huntington's disease: role of CB1 and CB2 receptors.
P2860
Q22242668-E535F563-98A5-4A06-BD77-955E0352488BQ22306292-2F408FDE-A926-4808-81C1-2EDC5BF7B1C9Q24633122-4ECEC932-B698-4A52-9FA3-DA4026D2A52CQ26747214-E536511A-491F-47F4-8B29-85F60EBCA5F4Q26769951-AB6B4675-0FD0-413E-925C-FF37364CE7D9Q26828403-8F79186B-5484-45B4-A979-E771DE35955AQ27302924-73491064-4CC2-4E16-861B-A86E655C5E91Q27325738-77E5FC72-8053-414B-B8AF-FDA3DC80E9BAQ27329150-EF9D625C-1E3C-4E5A-BA32-9CF4F40A5CD7Q27334472-5AD5E17E-E49D-4E9F-9D30-B3636E8D24CEQ28073952-C14D6369-9F3D-4C82-AA47-8D495C89CD25Q28277871-1FE79685-6E32-453B-8898-5FE057CBD089Q28305413-BD2A5D0C-F51F-4C0F-BC39-29CFEAC94E59Q28570135-9AD84960-1A21-49BE-8D37-11238E8BDE8CQ30410119-779870D6-3ABC-4251-8728-67D34DA3135EQ30506148-E18E1973-DB9B-4D8F-B352-942D1573DE18Q30530945-B17E9B65-6D33-4708-9F17-E20899959466Q33624653-FFB38938-40A6-4CC9-A652-6CB4D50BF0B9Q33664105-A48AD15F-FCAF-4CEE-9974-6178689944F3Q33687436-E6474218-83DB-459F-898B-C5B37DED6153Q33730578-96F238B9-C84D-4B24-8AC5-50BD81261A93Q33809556-5A0D05A4-FE22-4D1F-8A2A-EE1CB6C72AE6Q33959395-FEFE189B-24E6-4B63-90D0-E946EF9EE92EQ34098196-DCF38CE4-ABF9-40BD-BF3E-E3CE6F31A9D8Q34325190-EE6054A3-947B-41FC-BDA7-E60E5F39ECE1Q34440282-276C4994-B8F8-468A-A78A-183718316F47Q34496064-8AD6DFE8-3D25-4CE1-80E4-8F63C7B0A0AFQ34591087-308D955B-4233-4618-B8D7-0ECC0CBAAF4AQ34684334-B9EB14CC-EC09-465E-A382-0A4E8E3A3DB0Q34754667-EAF85BDF-979E-4AB8-8BFA-58DC0651410DQ35016514-D06DFEA8-7CF9-4FAB-B8AA-704969526C66Q35023230-AA954D4B-CAEE-4746-BD6B-56182E016CA7Q35103574-BBB1CE58-E54A-4B3A-90DD-B0102ADCF39DQ35125153-42A75ADD-48EB-4AAA-8DC5-15B8832D138AQ35171113-4F51D78D-B21B-4C2C-A38C-0D4FBD793BCFQ35271805-8CB11966-F63B-48B8-8CF4-5C0CA6490EC0Q35499568-B2536C06-D982-4EE5-8F04-7904834BE804Q35668816-D3D4F83A-0BA8-4A30-BA88-E01EFAE8A96BQ35674014-C918D28F-C8E5-4D27-9A38-349B1D56F1DFQ36056302-5349A350-49A4-4D01-BE5D-14641306B5C3
P2860
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Microglial CB2 cannabinoid rec ...... gton's disease excitotoxicity.
@en
Microglial CB2 cannabinoid rec ...... gton's disease excitotoxicity.
@nl
type
label
Microglial CB2 cannabinoid rec ...... gton's disease excitotoxicity.
@en
Microglial CB2 cannabinoid rec ...... gton's disease excitotoxicity.
@nl
prefLabel
Microglial CB2 cannabinoid rec ...... gton's disease excitotoxicity.
@en
Microglial CB2 cannabinoid rec ...... gton's disease excitotoxicity.
@nl
P2093
P50
P921
P356
P1433
P1476
Microglial CB2 cannabinoid rec ...... ngton's disease excitotoxicity
@en
P2093
Boris Julien
Carolina Carrasco
Cristina Benito
Javier Fernández-Ruiz
Manuel Guzmán
Tania Aguado
P304
P356
10.1093/BRAIN/AWP239
P407
P577
2009-10-05T00:00:00Z